Summary Cytogenetic and enzymatic studies have shown that chronic myeloid leukaemia (CML) represents the clonal proliferation of a pluripotent stem cell. The Philadelphia chromosome (Ph') is the characteristic karyotypic abnormality seen in this disease, although the exact role of this clonal marker in the pathogenesis of CML is uncertain. At a molecular level, the Ph' has recently been shown to represent the translocation of c-abl to a limited region (breakpoint cluster region, bcr) on chromosome 22. We have used probes for the bcr gene to obtain molecular evidence for the clonal origin of blast crisis in 2 patient with CML. In both cases, the first with myeloid and the second with lymphoid blast crisis, there was rearrangement of the bcr gene. The patterns of rearrangement varied between patients but were identical when comparing acute and chronic phases within the same individual. As the Ph' translocation is thought to represent a random recombination event, these data not only provide further evidence for the clonal origin of blast crisis in CML, but also suggest that in the second patient this translocation event had already occurred at the level of the pluripotent stem cell.
Chronic myeloid leukaemia (CML) represents the clonal proliferation of a pluripotent stem cell capable of differentiation into several haemopoietic cell types (Greaves et al., 1979) . These include the granulocytic, monocytic, erythroid, platelet, and lymphoid cell lineages (Fialkow et al., 1977) . Two lines of evidence support this statement. Firstly, in patients heterozygous for the X-linked isoenzyme, glucose-6-phosphate dehydrogenase (G6PD), involved tumour cells of varying lineages expressed a single, common G6PD allele (Fialkow et al., 1977) . Secondly, in over 95% of cases, cytogenetic studies have identified the Philadelphia chromosome (Ph') -a consistent karyotypic abnormality seen in both the chronic and acute phases of this disease (Rowley & Testa, 1983) . Fialkow has suggested that this cytogenetic marker is a secondary event occurring in an already transformed haemopoietic stem cell (Fialkow et al., 1981) , although more recent evidence suggests that the Philadelphia abnormality may be critical in the pathogenesis of CML (Adams, 1985) .
Using banding techniques, Rowley (1973) first demonstrated that the Philadelphia chromosome resulted from a reciprocal translocation between chromosomes 9 and 22, i.e. t(9; 22). However recently, molecular studies have determined that the critical genetic event underlying this karyotypic abnormality is the translocation (to chromosome 22) of the Abelson proto-oncogene c-abl, normally located on chromosome 9 (de Klein et al., 1982 (Groffen et al., 1984) .
We have used a probe for the bcr gene to confirm the clonal origin of blast crisis in two patients with CML. In addition, the results of these molecular studies suggest that the fusion of c-abl to the bcr gene -the molecular equivalent of the Philadelphia chromosome, has already occurred at the level of the pluripotent stem cell.
Patients and methods

Patients
The first patient was a 20 year old female with CML first diagnosed in July 1983. She remained in chronic phase for approximately 9 months but while being considered for bone marrow transplantation in April 1984, was noted to be in blast crisis. She was treated with high dose Ara-C but sustained only a partial response. Marrow samples harvested during the chronic and acute phase were available for study.
The the second episode of blast crisis were available for analysis. Both patients were Ph'-positive throughout the entire course of their disease and exhibited no additional cytogenetic abnormalities.
Methods
Sources of DNA DNA was prepared from peripheral blood or bone marrow cells of patients with CML either in chronic phase or during blast crisis. DNA prepared from the bone marrow of normal donors was used as a control. Isolation of DNA DNA was purified as previously described (Gusella et al., 1980) . In brief, cells were washed twice in PBS, resuspended in TNE (IOmM Tris/lOOmM NaCI/lmM EDTA pH 8.0) and added to an equal volume of TNE containing proteinase K (400 ug ml -1) and 1% NaDod S04. The suspension was incubated at 37°C for 4-16 h. The DNA was then extracted once with phenol/chloroform/isomylalcohol and several times with chloroform/isomylalcohol. The DNA was then precipitated with isopropanol and resuspended in 10mM Tris/l mM EDTA, pH 7.5. The concentration of DNA was determined by spectroscopy; the A260/A280 ratio was 1.8-2.0. Southern blot analysis Genomic DNA was cut with one of several restriction enzymes including EcoR1, Bgl II, or Hind III. Digested DNA was separated on 0.8% agarose gels and transferred (Southern 1975) to nylon membranes. The filters were hybridized in 0.75 M NaCl/0.075 M sodium citrate, pH 7.0/0.1% NaDod S04/0.02% Ficoll/0.02% bovine serum albumin/0.02% polyvinyl-pyrrolidone/50% formamide/10% dextran sulphate containing sonicated salmon sperm (200pgml-1) and radioactive probe (5 x 106 cpm ml-1). (Table I) . Tdt may be present on both T and B lymphocytes (Bollum, 1979) although Ta and cALLa expression correspond to early stages of B cell differentiation in which immunoglobulin heavy chain genes have been rearranged (Korsmeyer et al., 1983 (Figure 2 ). In the first patient, no evidence of immunoglobulin heavy chain gene rearrangement was detected. Both DNA samples (Figure 2 , Lane B, C) displayed a germ line configuration identical to the normal control ( Figure 2 , Lane A). In the second patient a comparison of DNA patterns revealed that immunoglobulin heavy chain genes had retained their germ line structure during the chronic phase of CML (Figure 2 , Lane D), but had rearranged during blast crisis (Figure 2 , Lane E). This latter observation not only confirms the lymphoid nature of blast crisis in this patient but assigns the blasts to the B cell lineage (Korsmeyer et al., 1983 
Discussion
This report describes two patients with Philadelphia positive CML terminating in blast crisis. In the first case (patient no. 1) the leukaemic blasts did not express lymphoid or myeloid antigens (Table I ) and the immunoglobulin heavy chain genes (Figure 2) were not rearranged. By contrast in the second patient, as well as having rearranged their heavy chain genes, the leukaemic blasts expressed several lymphoid antigens normally only present during the earliest stages of B-cell differentiation (Table I) . Thus, these patients have developed myeloid (based on morphologic rather than phenotypic criteria) and lymphoid blast crises respectively. Similar findings were reported by Bakhshi et al. (1983) who examined 18 cases of CML. Eight of the nine episodes of lymphoid crisis had heavy chain rearrangement whereas during the chronic myeloid, myeloid blast and erythroid phases of CML, cells were shown to have germ line immunoglobulin genes.
Both patients described in this report had a Philadelphia chromosome, the molecular equivalent of which is thought to be the translocation of c-abl to chromosome 22 with an associated structural reorganization of the bcr gene (Heisterkamp et al., 1985) . Rearrangement of this gene (bcr) was documented in both patients (Figures 3 & 4) . We have also observed varying patterns of rearrangement of the bcr gene in three other patients with lymphoid blast crisis (data not shown). At the molecular level, the Ph' translocation is felt to represent a random recombination event limited to a 5.8kb region of chromosome 22 (Heisterkamp et al., 1985) . This conclusion was based on the absence of sequence homology between different breakpoint regions of individual patients with CML. A detailed restriction enzyme analysis of 17 patients with proven or probable (based on molecular studies) Ph'-positive CML strongly supports this model of random recombination (Groffen et al., 1984) . In that report, the majority of patients studied had different patterns of bcr gene rearrangement. Similarly in our own study, restriction enzyme patterns varied between patients, but were identical when comparing the chronic myeloid and blastic phases within the one individual. Based on the proposed model, the last observation suggests that a common cell of origin gave rise to both the chronic myeloid and blastic phases of CML in each case.
In the second patient with lymphoid blast crisis (Table I and Figure 2 ), the finding of identical bcr restriction enzyme patterns (Figure 3 , Lanes D & E), not only suggests that the chronic myeloid and blastic phases of CML were derived from a single progenitor cell, but also that genetic recombination has already occurred at the level of the pluripotent stem cell. This concept extends the model proposed by Fialkow et al. (1981) . Based on the development of clonally-derived (implied by isoenzyme studies) Ph'-negative lymphoid cell lines from a patient with Ph'-positive CML, Fialkow suggested that the Ph' abnormality occurred as a secondary event in descendants of haemopoietic stem cell precursors. The molecular studies described herein do not preclude this hypothesis but based on a model of random recombination, the data presented suggest that rearrangement of the bcr gene -the molecular equivalent of the Ph' translocation, has already occurred in stem cells capable of myeloid or lymphoid differentiation. Evidence of the Ph' abnormality at the level of the pluripotent stem cell, in conjunction with recent data suggesting that the fusion of the bcr and abl genes in CML results in the production of a novel 8.7kb mRNA (Shtivelman et al., 1985) , implies that this marker may be critical in the pathogenesis of CML. However these results do not prove that the 9:22 translocation occurred during the initial transformation event. It is also of interest that since the same bcr-c-abl rearrangement is seen in both the acute and chronic phases in the same patient, progression into blast crisis does not appear to depend on further molecular alteration at the bcr-cabl locus. Further molecular studies are underway to define the exact role of the bcr and c-abl oncogenes in the biology of CML.
